For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

Immunotherapy let some cancer patients with mismatch repair deficient tumors completely avoid surgery, chemo and radiation, a ...

An artificial intelligence (AI)-based model developed by UT Southwestern Medical Center researchers can accurately predict ...

Immune checkpoint inhibitor-based combinations have become the preferred first-line therapy for patients with metastatic clear cell renal cell carcinoma, but more than a third of eligible patients do ...

Prophylactic IV magnesium is associated with a reduced risk for cisplatin-associated acute kidney injury in patients with ...

Patients in South Korea with rheumatoid arthritis were associated with a greater risk of developing kidney cancer, but not bladder, prostate, or testicular cancers. Individuals with rheumatoid ...

A simple urine test could accurately show the recurrence of kidney cancer at an early stage, potentially sparing patients ...

Although recommended, many patients with metastatic clear cell RCC still don’t receive immune checkpoint inhibitor-based combinations as first-line treatment.

The solid cash conversion allows Telix to internally fund organic growth and flexibility to pursue acquisitions. We expect the company to reinvest the majority of earnings into R&D. We forecast ...

The average age for someone diagnosed with Kidney Cancer in the U.S. is 65. But one local man’s decades-long battle with ...

A review finds gaps in patient-nephrologist communication in advanced kidney disease, including care planning and dialysis, ...